Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity
(NASDAQ: CRBP) Delayed: 8.12 -0.12 (1.46%)
Previous Close $8.24    52 Week High $10.78 
Open $8.38    52 Week Low $1.01 
Day High $8.50    P/E N/A 
Day Low $7.95    EPS $0.00 
Volume 2,268,595